| 1 |
Perretti M, Dalli J. Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation. Annu Rev Pharmacol Toxicol 2023;63:449-69. [PMID: 36151051 DOI: 10.1146/annurev-pharmtox-051821-042743] [Reference Citation Analysis]
|
| 2 |
Díaz Del Campo LS, García-Redondo AB, Rodríguez C, Zaragoza C, Duro-Sánchez S, Palmas F, de Benito-Bueno A, Socuéllamos PG, Peraza DA, Rodrigues-Díez R, Valenzuela C, Dalli J, Salaices M, Briones AM. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension. Hypertension 2023;80:84-96. [PMID: 36337053 DOI: 10.1161/HYPERTENSIONAHA.122.19448] [Reference Citation Analysis]
|
| 3 |
Perretti M, Subramanian M. Resolution pharmacology - A fresh approach to the clinical management of human inflammatory diseases. Semin Immunol 2023;65:101669. [PMID: 36565567 DOI: 10.1016/j.smim.2022.101669] [Reference Citation Analysis]
|
| 4 |
Sugimoto MA, Perucci LO, Tavares LP, Teixeira MM, Sousa LP. Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation. Curr Drug Targets 2022;23:1578-92. [PMID: 36221881 DOI: 10.2174/1389450123666221011102250] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Liu C, Fan D, Lei Q, Lu A, He X. Roles of Resolvins in Chronic Inflammatory Response. Int J Mol Sci 2022;23. [PMID: 36499209 DOI: 10.3390/ijms232314883] [Reference Citation Analysis]
|
| 6 |
Nshimiyimana R, Fung Lam T, Aggarwal S, G. Bazan N, Bazan HE, Petasis NA. First total synthesis of 4(R),17(R)-Resolvin D6 stereoisomer, a potent neuroprotective docosanoid. Tetrahedron Letters 2022;106:154091. [DOI: 10.1016/j.tetlet.2022.154091] [Reference Citation Analysis]
|
| 7 |
Djuricic I, Calder PC. Polyunsaturated fatty acids and metabolic health: novel insights. Curr Opin Clin Nutr Metab Care 2022. [PMID: 35943130 DOI: 10.1097/MCO.0000000000000865] [Reference Citation Analysis]
|
| 8 |
Torshin IY, Gromova OA. Biophysical modeling indicates a high affinity of ethyl esters of omega-3 polyunsaturated fatty acids to the enzymes of the pro-inflammatory arachidonic acid cascade. Farmakoèkonomika 2022;15:221-229. [DOI: 10.17749/2070-4909/farmakoekonomika.2022.142] [Reference Citation Analysis]
|
| 9 |
Díaz Del Campo LS, Rodrigues-Díez R, Salaices M, Briones AM, García-Redondo AB. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling. Int J Mol Sci 2022;23:3592. [PMID: 35408952 DOI: 10.3390/ijms23073592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
